Baird raised the firm’s price target on Healthpeak Properties (DOC) to $25 from $24 and keeps an Outperform rating on the shares. The firm said they are closing the year with momentum on all aspects of the business. Baird continues to like the company for its attractive valuation and improving fundamentals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties Reports Strong Q3 2024 Results
- Healthpeak Properties narrows FY24 AFFO view to $1.56-$1.58 from $1.54-$1.58
- Healthpeak Properties reports Q3 AFFO 41c, consensus 44c
- Deutsche upgrades Healthpeak to Buy on improving life sciences sector
- Healthpeak Properties upgraded to Buy from Hold at Deutsche Bank